DICER1
DICER1 (Endoribonuclease Dicer) is an enzyme. The public catalogues list it as an oncogene driver, a tumour suppressor and a biomarker, and clinical evidence ties its variants to diagnosis, prognosis or drug response. Tied to Lung cancer, Sarcomas, Brain and spinal cord tumours and 5 more. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Biology
Double-stranded RNA (dsRNA) endoribonuclease playing a central role in short dsRNA-mediated post-transcriptional gene silencing. Cleaves naturally occurring long dsRNAs and short hairpin pre-microRNAs (miRNA) into fragments of twenty-one to twenty-three nucleotides with 3' overhang of two nucleotides, producing respectively short interfering RNAs (siRNA) and mature microRNAs. SiRNAs and miRNAs serve as guide to direct the RNA-induced silencing complex (RISC) to complementary RNAs to degrade them or prevent their translation. Gene silencing mediated by siRNAs, also called RNA interference, controls the elimination of transcripts from mobile and repetitive DNA elements of the genome but also the degradation of exogenous RNA of viral origin for instance. The miRNA pathway on the other side is a mean to specifically regulate the expression of target genes. Location: Cytoplasm; Cytoplasm, perinuclear region (UniProt). Locus 14q32.13 (HGNC).
- Lung cancer: Open Targets association 0.80 with lung cancer (MONDO_0008903)
- Sarcomas: Open Targets association 0.79 with sarcoma (MONDO_0005089)
- Brain and spinal cord tumours: Open Targets association 0.66 with brain cancer (MONDO_0001657)
- Ovarian cancer: Open Targets association 0.62 with ovarian cancer (MONDO_0008170)
- Skin cancer: Open Targets association 0.57 with skin cancer (MONDO_0002898)
- Colorectal cancer: Open Targets association 0.56 with colorectal cancer (MONDO_0005575); IntOGen driver in 1 cohort (COADREAD)
External identifiers
Built from HGNC, Ensembl, UniProt and ChEMBL idsProducts by modality and phase
Browse products →No product in the corpus is aimed at this target yet.
Trials
Evidence ranking →No trial in the corpus names this target or one of its products.
Resistance routes
Unaddressed routes →The resistance atlas has no route that names this target.
Pathways
Pathway-to-drug matrix →No pathway diagram carries this target as a node.
Companion diagnostics
Assay registry →No companion diagnostic in the registry measures this target.
Preclinical models
All models →No model entry for this target yet; check the cancer entries on the models page.
Open questions
All open questions →No open questions recorded for this target yet. Suggest one.
Literature
Preprints →Query for this target: (TITLE:"DICER1" OR ABSTRACT:"DICER1" OR TITLE:"dicer 1, ribonuclease III" OR ABSTRACT:"dicer 1, ribonuclease III" OR TITLE:"Endoribonuclease Dicer" OR ABSTRACT:"Endoribonuclease Dicer" OR TITLE:"Dicer" OR ABSTRACT:"Dicer" OR TITLE:"KIAA0928" OR ABSTRACT:"KIAA0928" OR TITLE:"K12H4.8-LIKE" OR ABSTRACT:"K12H4.8-LIKE") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about DICER1, not a curated reading list.
Export
The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/dicer1.json. Licence CC BY-NC 4.0.